ABOUT INDEXING BOARD ARCHIVES AUTHOR GUIDELINES SUBMIT PAPER AUTHOR'S PAGE NEWS, EVENTS CONTACT
REVISTA DE CHIMIE
Cite as: Rev. Chim.
https://doi.org/10.37358/Rev.Chim.1949

OSIM Nr. R102355
ISSN Online 2668-8212
ISSN Print: 1582-9049
ISSN-L: 1582-9049

REVISTA DE CHIMIE Latest Issue

LATEST ISSUE >>>

   Volume 77, 2026
   Volume 76, 2025
   Volume 75, 2024
   Volume 74, 2023
   Volume 73, 2022
   Volume 72, 2021
   Volume 71, 2020
   Volume 70, 2019
   Volume 69, 2018
   Volume 68, 2017
   Volume 67, 2016
   Volume 66, 2015
   Volume 65, 2014
   Volume 64, 2013
   Volume 63, 2012
   Volume 62, 2011
   Volume 61, 2010
   Volume 60, 2009
   Volume 59, 2008
   Volume 58, 2007
 
<<<< back

Revista de Chimie (Rev. Chim.), Year 2016, Volume 67, Issue 5,





GRIGORE TINICA, RALUCA OZANA CHISTOL, MARIA MAGDALENA LEON CONSTANTIN, ANISIA IULIANA ALEXA, STEFAN CONSTANTIN, CRISTINA FURNICA
N-acetylcysteine for Prevention of Postoperative Renal Failure

Abstract:

Several pharmaceutical agents have been proposed as protective factors against acute renal failure, from which N-acetylcysteine gained a particular interest. The aim of the current research is to evaluate NAC ability of preventing ARF in patients with chronic kidney disease (CKD) undergoing coronary artery bypass grafting (CABG). The authors analyzed 92 patients with preoperative CKD that benefited from CABG between 2000-2010. 44 of the 92 patients received intravenous NAC immediately after cardiopulmonary bypass cessation while the remaining 48 patients did not receive any particular medication. Postoperatively, estimated glomerular filtration ratio (eGFR) decreased with 14.73% in patients that did not receive NAC and with 13.1% in patients that received NAC (p = 0.07). From the 14 patients that required hemodialysis, 6 received NAC (13.67%) and 8 did non receive NAC (16.67%) (p = 0.55). ICU admission was similar for the two groups of patients (8.71 days in NAC group and 8.52 days in the no NAC group) (p = 0.15). The 2 patients with CKD that did not survive the first 30 days were not treated with NAC. No adverse effects to NAC and no statistically significant difference concerning the incidence of postoperative complications were noticed in the study group. Thus, the results of the current study suggest that NAC administration in patients with CKD brings little to no benefit in the prevention of postoperative ARF. Keywords: N-acetylcysteine, pharmaceutical agents, oxidative stress, glutathione, cysteine, estimated glomerular filtration ratio

Issue: 2016, Volume 67, Issue 5
Pages:
download pdf   Download Pdf Article
Creative Commons License
This article is published under the Creative Commons Attribution 4.0 International License
 
<<<< back
 
PUBLISHING SECTION
Author Guidelines
 * Paper Drafting
 * Paper Template
 * Ethical Statement
 * Paper Submission
Ghidul Autorului (ro)
Submit Paper
Author's Page
Publishing Ethics
Peer Review Process
Open Access & Archiving Policy
 Search Authors
 LATEST NEWS
REvista de Chimie NUMAR OMAGIAL PETRU PONI.. detalii
REvista de Chimie Revista de Chimie - 70 de ani de aparitie neintrerupta.. detalii
dictionar English-Romanian Dictionary for Mechanical Engineering
(download pdf)
  News, Events
Crossref Member Badge
 DOI  logo
 Gold Open Access | Source=http://www.plos.org/  | Author=art designer at PLoS
Creative Commons License
 Conferences of Contemporary
 Chemistry
 Biblioteca Chimiei
 Materiale Plastice